| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |